Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Development of the Heart01:27

Development of the Heart

949
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
949
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Restorative Care01:19

Restorative Care

2.0K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dysregulated calcium signaling underlies hyposalivation and microbial dysbiosis in Down syndrome.

Cell reports·2026
Same author

Delivering transformational change for patients and the environment through England's National Cancer Plan.

The Lancet. Oncology·2026
Same author

Cost-effectiveness of N-terminal pro-B-type natriuretic peptide thresholds for echocardiography referral in primary care heart failure management.

Heart (British Cardiac Society)·2026
Same author

Prevention of heart failure.

European heart journal·2026
Same author

Role of community pharmacy in the prevention of cardiovascular disease in minority ethnic groups in the UK including barriers and facilitators: a mixed-methods systematic review.

BMJ open·2026
Same author

Exploring Medication Adherence in Heart Failure From a Patient Perspective: A Qualitative Study.

Circulation. Heart failure·2026
Same journal

Beyond the slope: prognostic utility of the VE/VCO<sub>2</sub> intercept in chronic heart failure.

Open heart·2026
Same journal

Impact of socioeconomic deprivation on early and long-term outcomes after major aortic surgery: insights from a 20-year single-centre cohort.

Open heart·2026
Same journal

Rethinking rate-related myocardial injury in sepsis: atrial fibrillation, heart rate, cardiac troponin T and long-term mortality.

Open heart·2026
Same journal

Treatment and control of low-density lipoprotein for primary prevention in patients in Wales with and without depression: a study of whole-population electronic health records.

Open heart·2026
Same journal

Equitable lipid optimisation through a data-driven, pharmacist-led secondary prevention pathway.

Open heart·2026
Same journal

Early versus delayed EKOS thrombolysis in intermediate-high risk pulmonary embolism: a retrospective multicentre analysis.

Open heart·2026
查看所有相关文章

相关实验视频

Updated: Jul 5, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

793

多专业心力衰竭自我发展框架

Paul Forsyth1, Susan Young2, Kirsty Hughes3

  • 1Pharmacy, NHS Greater Glasgow and Clyde, Glasgow, UK.

Open heart
|January 19, 2024
PubMed
概括
此摘要是机器生成的。

这项研究定义了医生和护士以外的医疗保健专业人员的核心心力衰竭能力. 它强调了一种多学科的方法来复杂的病人护理.

关键词:
临床能力 临床能力教育, 医学, 医疗这是心脏衰竭.

更多相关视频

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.9K

相关实验视频

Last Updated: Jul 5, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

793
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.9K

科学领域:

  • 心脏病学 心脏病学
  • 医疗保健专业教育 医疗保健专业教育

背景情况:

  • 心力衰竭是一个全球性公共卫生问题,特别影响老年人.
  • 现有的心力衰竭能力框架主要针对医生,护士和药剂师.
  • 复杂的患者需求往往超出标准的医疗干预范围,包括脆弱性,康复和社会护理.

研究的目的:

  • 发展一个专家的共识,基本的心力衰竭的特定能力.
  • 将重点扩展到传统角色之外,包括相关的卫生专业人员和心脏生理学家.
  • 为更广泛的多学科心力衰竭护理方法创造框架.

主要方法:

  • 组建一个由各种各样的医疗保健专业人员组成的专家工作组.
  • 对现有的课程和能力框架进行全面的文献审查.
  • 建立共识的过程,以代的框架开发和专业特定的调整.
  • 正式的撰写和传播策略,以最大限度地提高项目影响.

主要成果:

  • 制定了一个详细的能力框架,包括七个关键部分.
  • 部分包括知识 (综合征,诊断,管理),一般和心力衰竭特定技能,临床自主性和多学科团队合作.
  • 该框架还涵盖了教学,教育,研究和开发能力.

结论:

  • 心力衰竭患者具有复杂的需求,需要来自各种各样的专业的投入.
  • 这一框架强调了更广泛的多学科团队在治疗心力衰竭方面的关键作用.
  • 它旨在为与这些患者互动的专业人员定义核心,通用心力衰竭特定的能力.